FDA approves first nasal spray flu vaccine for use at home
FluMist is the only nasal flu vaccine, but it is not new. The FDA approved it in 2003 for people 5 to 49 years old before expanding eligibility in 2007 to children as young as 2 years old — requiring in both instances that it be administered by a vaccine provider.
If you’ve received the COVID-19 vaccine, you may have experienced common side effects such as pain, fatigue, or fever, or ...
Covid-19 levels in the United States are high and rising, flu season is approaching quickly and RSV cases are already ...
The Suffolk GP Federation, a collective of surgeries in the county, was sent a large batch of the AstraZeneca vaccine with a ...
Health.com on MSN8d
Guide to 2024 Fall Vaccines: When to Get Your COVID, Flu, and RSV ShotsVaccines for the Fall and Winter 2024–2025 season are now available. Generally, experts recommend COVID-19 and flu vaccines ...
The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...
The World Health Organization announced Friday it has authorized the use of an mpox vaccine, calling it an “important step” ...
And now that “cold and flu” season has become COVID-19, cold, flu and RSV season, medical experts are urging folks to head to ...
The seasonal influenza [flu] vaccine is available for priority groups through their doctor or the Flu Express,” the ...
(Family Features) Even though cooler days may seem far off, now is the best time to plan ahead for a healthy winter. One ...
Experimental mRNA cancer vaccine shows potential for advanced stage cancer patients in Phase 1 trial
Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients with advanced solid cancers. The investigational mRNA cancer immunotherapy is ...
Two recent studies reveal that the efficacy of Bavarian Nordic's Mpox vaccine significantly declines within 6-12 months ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback